Revenue · 2011–2025
Ani Pharmaceuticals revenue
$883M+43.8% · FY2025
Ani Pharmaceuticals (ANIP) reported $883M in revenue for fiscal 2025, +43.8% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $883M | +43.8% | Open → |
| FY20242024-12-31 | $614M | +26.2% | Open → |
| FY20232023-12-31 | $487M | +53.9% | Open → |
| FY20222022-12-31 | $316M | +46.4% | Open → |
| FY20212021-12-31 | $216M | +3.7% | Open → |
| FY20202020-12-31 | $208M | +0.9% | Open → |
| FY20192019-12-31 | $207M | +2.5% | Open → |
| FY20182018-12-31 | $202M | +14.0% | Open → |
| FY20172017-12-31 | $177M | +37.5% | Open → |
| FY20162016-12-31 | $129M | +68.5% | Open → |
| FY20152015-12-31 | $76.3M | +36.4% | Open → |
| FY20142014-12-31 | $56.0M | +86.1% | Open → |
| FY20132013-12-31 | $30.1M | +47.7% | Open → |
| FY20122012-12-31 | $20.4M | +4,581.3% | Open → |
| FY20112011-12-31 | $435,160 | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +72.3%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ani Pharmaceuticals revenue |url=https://companiesranked.com/en/company/ani-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ani Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/ani-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-ani-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Ani Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ani-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001023024-26-000014 · February 27, 2026
{{cite web |title=Ani Pharmaceuticals revenue — 10-K (0001023024-26-000014) |url=https://www.sec.gov/Archives/edgar/data/1023024/000102302426000014/anip-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.